Total Payments
$3,626
2024 Payments
$1,573
Companies
22
Transactions
200
Medicare Patients
774
Medicare Billing
$53,653
Payment Breakdown by Category
Food & Beverage$3,626 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,626 | 200 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $926.62 | 53 | $0 (2024) |
| Lilly USA, LLC | $710.81 | 31 | $0 (2024) |
| Novo Nordisk Inc | $412.52 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $384.89 | 28 | $0 (2024) |
| Axsome Therapeutics, Inc. | $243.60 | 9 | $0 (2024) |
| PFIZER INC. | $165.30 | 12 | $0 (2024) |
| Amgen Inc. | $125.05 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $115.86 | 6 | $0 (2024) |
| Exact Sciences Corporation | $102.44 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $80.24 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,573 | 86 | ABBVIE INC. ($307.43) |
| 2023 | $1,753 | 98 | AbbVie Inc. ($619.19) |
| 2022 | $300.31 | 16 | Amgen Inc. ($61.66) |
All Payment Transactions
200 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Obesity | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: Obesity | ||||||
| 11/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/29/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: VACCINES | ||||||
| 09/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: PAIN | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Cardio-renal | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: VACCINES | ||||||
| 08/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 610 | 742 | $101,126 | $43,714 |
| 2022 | 7 | 164 | 169 | $19,964 | $9,938 |
Total Patients
774
Total Services
911
Medicare Billing
$53,653
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 204 | $36,720 | $14,131 | 38.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $20,900 | $9,075 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 106 | $14,310 | $5,649 | 39.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 25 | 26 | $8,970 | $3,773 | 42.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 52 | 53 | $5,830 | $3,734 | 64.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $5,775 | $3,102 | 53.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 58 | 59 | $2,242 | $1,573 | 70.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 84 | 112 | $1,792 | $924.60 | 51.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 19 | 19 | $1,900 | $571.72 | 30.1% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 15 | 15 | $1,350 | $533.68 | 39.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $418.00 | $314.60 | 75.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 22 | 28 | $644.00 | $230.94 | 35.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 11 | 11 | $132.00 | $56.16 | 42.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 11 | 11 | $143.00 | $46.82 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 32 | $5,760 | $2,769 | 48.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 17 | 17 | $4,675 | $2,061 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 29 | $3,915 | $1,920 | 49.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 28 | 28 | $3,080 | $1,919 | 62.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $1,102 | $781.26 | 70.9% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 12 | 12 | $1,080 | $427.68 | 39.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 21 | 22 | $352.00 | $59.66 | 16.9% |
About Dr. Abby Lauer, MD
Dr. Abby Lauer, MD is a Internal Medicine healthcare provider based in Newport, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2017. The National Provider Identifier (NPI) number assigned to this provider is 1902339294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abby Lauer, MD has received a total of $3,626 in payments from pharmaceutical and medical device companies, with $1,573 received in 2024. These payments were reported across 200 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,626).
As a Medicare-enrolled provider, Lauer has provided services to 774 Medicare beneficiaries, totaling 911 services with total Medicare billing of $53,653. Data is available for 2 years (2022–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Newport, KY
- Active Since 04/04/2017
- Last Updated 01/08/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902339294
Products in Payments
- MOUNJARO (Drug) $592.05
- VRAYLAR (Drug) $568.89
- TRELEGY ELLIPTA (Drug) $289.44
- Auvelity (Drug) $243.60
- QULIPTA (Drug) $230.69
- UBRELVY (Drug) $127.04
- JARDIANCE (Drug) $116.93
- ENTRESTO (Drug) $115.86
- Rybelsus (Drug) $112.80
- Wegovy (Drug) $112.31
- Otezla (Drug) $110.59
- Cologuard Collection Kit (Device) $102.44
- Ozempic (Drug) $101.36
- SHINGRIX (Biological) $84.74
- ELIQUIS (Drug) $64.96
- NURTEC ODT (Drug) $53.47
- GRALISE (Drug) $51.55
- QUVIVIQ (Drug) $49.01
- Kerendia (Drug) $48.63
- EMGALITY (Drug) $48.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newport
Candi Overholt, Md, MD
Internal Medicine — Payments: $18,838
Internal Medicine $18,838
Mr. Anton Daniel, Md, MD
Internal Medicine — Payments: $18,405
Internal Medicine $18,405
Niva Khan, M.d, M.D
Internal Medicine — Payments: $6,286
Internal Medicine $6,286
Vijoydeep Tanjore Venkoba Rao, Md, MD
Internal Medicine — Payments: $5,723
Internal Medicine $5,723
Dr. Adrian Velasquez, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $5,261
Internal Medicine $5,261
Nazmul Hoque, Md, MD
Internal Medicine — Payments: $2,851
Internal Medicine $2,851